Arvinas Inc reports results for the quarter ended March 31 - Earnings Summary

Arvinas

01/05/2025 14:31

Arvinas Inc ARVN.OQ reported quarterly adjusted earnings of $1.14​​ per share for the quarter ended March 31, higher than the same quarter last year, when the company reported EPS of -97 cents.  The mean expectation of seventeen analysts for the quarter was for a loss of 95 cents per share. Wall Street expected results to range from $-1.35 to -51 cents per share.

Revenue rose 646.2% to $188.80 million from a year ago; analysts expected $41.59 million.

Arvinas Inc's reported EPS for the quarter was $1.14​.

The company reported quarterly net income of $82.9 million.

Arvinas Inc shares had risen by 37.0% this quarter and lost 49.8% so far this year.

FORECAST CHANGES

The mean earnings estimate of analysts had risen by about 24.8% in the last three months.​

In the last 30 days, one analyst negatively revised an earnings estimate

RECOMMENDATIONS

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 16 "strong buy" or "buy," 5 "hold" and no "sell" or "strong sell." The average consensus recommendation for the biotechnology & medical research peer group is also "buy"

Wall Street's median 12-month price target for Arvinas Inc is $25.00

This summary was machine generated from LSEG data May 1 at 01:31 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

QUARTER ENDING
ESTIMATE
ACTUAL
BEAT, MET, MISSED
Mar. 31 2025
-0.95
1.14
Beat
Dec. 31 2024
-1.02
-0.63
Beat
Sep. 30 2024
-0.96
-0.68
Beat
Jun. 30 2024
-0.86
-0.49
Beat